Interacting Drugs |
Famotidine vs Mesalamine |
Security Level |
 |
Mechanism |
Mesalamine: H2-Antagonists may diminish the therapeutic effect of Mesalamine. Histamine H2-Antagonist-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products. |
Management |
Consider avoiding concurrent administration of high-dose histamine H2-receptor antagonists with sustained-release mesalamine products. |
Famotidine vs Mesalamine
Post Review about Famotidine vs Mesalamine Click here to cancel reply.
Other Interactions of Famotidine
Other Interactions of Mesalamine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.